1417 POSTER A Phase II Trial of Afatinib (BIBW 2992) in Patients With Tumours Prospectively Screened for EGFR And/or HER2 Gene Amplification or EGFR Activating Mutations von Kwak, E.L, Shapiro, G.I, Cohen, S.M, Becerra, C.R, Lenz, H.J, Gooden, S, Robohn, M, Le-Maulf, F, Chand, V.K, lafrate, A.J

Volltext

Predictive design of multimonomeric polyelectrolytes enables lung-specific gene delivery von Ting, Jeffrey M, Fisher, John D, Conyers, Tyler, Patil, Suteja, Robohn, Catherine G, Tamayo-Mendoza, Teresa, Oviedo, Felipe, Murthy, Shashi K

Volltext

Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation von Kwak, Eunice L., Shapiro, Geoffrey I., Cohen, Seth M., Becerra, Carlos R., Lenz, Heinz‐Josef, Cheng, Wen‐Fang, Su, Wu-Chou, Robohn, Meghan, Le Maulf, Florence, Lobmeyer, Maximilian T., Chand, Vikram K., Iafrate, A. John

Volltext

Real-time scheduling in computer integrated manufacturing: a review of recent research von HARMONOSKY, C.M., ROBOHN, S. F.

Volltext

Investigating the application potential of simulation to real-time control decisions von HARMONOSKY, CATHERINE M., ROBOHN, SCOTT F.

Volltext